Playback speed
×
Share post
Share post at current time
0:00
/
0:00
Transcript
1

Matt Stoller on U.S. Monopolies, Political Dynamics of Corporate Power, and Antitrust Enforcement

Lead-Lag Live Video Of The Week
1

What if the American economy's foundation was built on small businesses rather than colossal corporations? Discover how we shifted from a decentralized landscape in the 1970s to today's monopolistic giants with our guest, Matt Stoller, an eminent public intellectual and author on monopolies and finance. Stoller reveals the philosophical shift that prioritized consumerism over citizenship, leading to a relaxation in antitrust laws and a landscape dominated by corporate mega-powers. Learn how this transition has created an economy riddled with extraction and bottlenecks, and how recent administrations are hinting at potential reforms to address these seismic changes.

We also delve deep into the political arena, examining how corporate power shapes the strategies of key political figures like Donald Trump and Kamala Harris. Trump’s evolution towards a traditional Republican stance is contrasted with Harris's nuanced and often contradictory relationship with corporate power and Silicon Valley. Gain insight into Harris’s mixed record as California's Attorney General and the potential influences from powerful entities like Wall Street and labor unions that could sway future policies. This chapter is a compelling look at the intricate dance between politics and corporate dominance.

If you enjoy this interview, consider joining the few who understand this as a full-access subscriber of The Lead-Lag Report through a paid subscription.

Get 30% off for 1 year

On the global stage, Stoller tackles the complexities of antitrust enforcement, revealing the partisan divides that complicate the legislative process in the U.S. and similar challenges worldwide. Hear about the prolonged antitrust cases, such as the ongoing investigation into Google's monopoly, and the urgent need for more efficient enforcement. We also unpack the murky waters of pharmaceutical pricing, highlighting the significant role of pharmacy benefit managers in drug distribution and costs. This episode is a must-listen for those keen on understanding the systemic issues plaguing major industries and the emerging reform movements aimed at dismantling monopolistic control.


The content in this program is for informational purposes only. You should not construe any information or other material as investment, financial, tax, or other advice. The views expressed by the participants are solely their own. A participant may have taken or recommended any investment position discussed, but may close such position or alter its recommendation at any time without notice. Nothing contained in this program constitutes a solicitation, recommendation, endorsement, or offer to buy or sell any securities or other financial instruments in any jurisdiction. Please consult your own investment or financial advisor for advice related to all investment decisions.

Discussion about this podcast